Arginine Grafting
Arginine Grafting - Related Videos
07:37
Mouse Models for Graft Arteriosclerosis
0 Views •
Cited by 17 •
2013
We describe protocols for our mouse graft arteriosclerois (GA) models which involve interposition of a mouse vessel segment into a recipient of the same inbred strain. By backcrossing additional genetic changes into the vessel donor, the model can assess the effect of specific genes on GA.
12:02
An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity
0 Views •
Cited by 8 •
2016
A protocol to synthesize peptoids with mixed cationic functionality in the same sequence is presented (lysine- and arginine-type monomers). Subsequent testing of these compounds against Leishmania mexicana, the protozoan parasites that cause cutaneous leishmaniasis, is also described.
03:35
A Technique for Human Skin Grafting in a Mouse Model
0 Views •
2025
This video demonstrates a method for grafting human skin onto an immunodeficient mouse with a suppressed neutrophil response. The method involves applying human split-thickness skin to the mouse's graft bed, sealing it, and covering it for recovery. Eventually, the human skin adheres to the mouse's skin, establishing vascularization and circulation, resulting in a successful skin xenograft.
05:47
Isolation and Transplantation of Different Aged Murine Thymic Grafts.
0 Views •
Cited by 14 •
2015
This report provides a detailed description of transplanting murine thymi from different aged donor mice under the kidney capsule of immunodeficient mouse recipients. The goal of this approach is to model T cell development and thymic selection events in vivo.
13:04
Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
0 Views •
Cited by 13 •
2015
Here, we present a protocol to generate tissue engineered vessel grafts that are functional for grafting into mice by double seeding partially induced pluripotent stem cell (PiPSC) - derived smooth muscle cells and PiPSC - derived endothelial cells on a decellularized vessel scaffold bioreactor.
FAQs
The guanidinium group is the main interaction-bearing feature after arginine is attached. Because it is positively charged, it can associate with negatively charged cell surfaces, proteins, membranes, and nucleic acids. These interactions can change how a functionalized material binds biological components or associates with cargo, making guanidinium chemistry especially relevant to engineered interfaces and delivery systems.
Arginine’s amino and carboxyl groups provide the chemical handles for attachment through coupling reactions, whereas the guanidinium group remains available to influence biological interactions. This separation of roles allows the attachment chemistry and the resulting surface behavior to be considered together. Linker chemistry can further shape how the arginine-containing group is presented and therefore how the engineered material performs.
Grafting density is a key control variable because it determines how many arginine-derived interaction sites are presented on the engineered material. Changing density can therefore alter surface charge, molecular binding, cell adhesion, or cargo association. Density should be interpreted alongside linker chemistry, since both variables help determine the final physicochemical properties and biological response.
Arginine grafting can be applied to different engineered substrates, including biomolecules, polymers, hydrogels, and other materials. The same chemical strategy may consequently produce different outcomes depending on the substrate and on whether the goal is to influence cells, proteins, membranes, nucleic acids, or cargo. This substrate-specific view is important when translating the approach across bioengineering designs.
A practical design sequence begins by selecting the biomolecule or material to be functionalized, identifying available amino or carboxyl groups for coupling, and choosing suitable linker chemistry. The arginine-containing group is then attached covalently, with grafting density treated as a controllable design parameter. The resulting construct can be examined for changes in binding, charge-related behavior, adhesion, or cargo association.
Functionalized scaffolds and coatings use the strategy to modify interactions at engineered surfaces, while nanoparticles and delivery systems use it to support molecular or cargo association. In each case, the intended outcome depends on how the attached arginine groups interact with negatively charged biological components. Bioengineering studies can therefore compare designs through their cell adhesion, molecular binding, physicochemical behavior, or biological response.